Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
By Dr. Liji Thomas, MD A growing body of research suggests that the gut microbiome may influence the hormonal and metabolic disruptions seen in PCOS. Scientists now propose that postbiotics, bioactive ...
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...